Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Viberzi (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D)

Drug Name (Brand / Generic)

Viberzi / eluxadoline

Developed by

Actavis

Therapy Class

Mixed opioid receptor

Current Indication

Irritable Bowel Syndrome with Diarrhoea (IBS-D)

Market Sector

Gastroenterology

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top